Exencial Wealth Advisors LLC Reduces Position in CVS Health Corporation $CVS

Exencial Wealth Advisors LLC lessened its stake in shares of CVS Health Corporation (NYSE:CVS) by 3.9% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 43,062 shares of the pharmacy operator’s stock after selling 1,742 shares during the period. Exencial Wealth Advisors LLC’s holdings in CVS Health were worth $2,970,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the stock. Harbor Asset Planning Inc. purchased a new stake in shares of CVS Health in the 2nd quarter valued at $30,000. Bell Investment Advisors Inc boosted its holdings in shares of CVS Health by 119.8% in the 1st quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock valued at $31,000 after acquiring an additional 248 shares during the last quarter. Roxbury Financial LLC boosted its holdings in shares of CVS Health by 78.3% in the 2nd quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock valued at $32,000 after acquiring an additional 202 shares during the last quarter. ORG Partners LLC boosted its holdings in shares of CVS Health by 418.9% in the 2nd quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock valued at $32,000 after acquiring an additional 377 shares during the last quarter. Finally, Saudi Central Bank purchased a new stake in shares of CVS Health in the 1st quarter valued at $34,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently commented on CVS shares. Leerink Partners upped their price objective on shares of CVS Health from $86.00 to $95.00 and gave the company an “outperform” rating in a report on Thursday, October 16th. Bernstein Bank dropped their price objective on shares of CVS Health from $78.00 to $72.00 and set a “market perform” rating on the stock in a report on Wednesday, July 16th. Barclays upped their price objective on shares of CVS Health from $80.00 to $87.00 and gave the company an “overweight” rating in a report on Thursday, September 4th. Sanford C. Bernstein upped their price objective on shares of CVS Health from $72.00 to $77.00 and gave the company a “market perform” rating in a report on Friday, September 5th. Finally, Wall Street Zen raised shares of CVS Health from a “hold” rating to a “buy” rating in a report on Sunday, September 21st. Two investment analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, CVS Health has an average rating of “Moderate Buy” and a consensus price target of $82.57.

CVS Health Stock Performance

CVS opened at $82.08 on Thursday. The company has a quick ratio of 0.62, a current ratio of 0.80 and a debt-to-equity ratio of 0.74. The company has a market cap of $104.11 billion, a price-to-earnings ratio of 22.93, a PEG ratio of 0.92 and a beta of 0.60. CVS Health Corporation has a 52-week low of $43.56 and a 52-week high of $83.52. The firm’s fifty day simple moving average is $75.02 and its two-hundred day simple moving average is $68.45.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.46 by $0.35. The business had revenue of $98.92 billion for the quarter, compared to the consensus estimate of $94.87 billion. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The company’s revenue was up 8.4% compared to the same quarter last year. During the same period last year, the firm posted $1.83 earnings per share. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. Equities analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd will be given a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.2%. The ex-dividend date is Thursday, October 23rd. CVS Health’s dividend payout ratio is 74.30%.

Insider Activity at CVS Health

In other news, Director Anne A. Finucane sold 7,500 shares of the stock in a transaction dated Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total value of $532,650.00. Following the completion of the sale, the director directly owned 22,156 shares in the company, valued at $1,573,519.12. This represents a 25.29% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 1.22% of the stock is owned by company insiders.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.